SG45439A1 - Separation of e nantiomers of cimaterol (-)-cimaterol and the use thereof as pharmaceutical composition or as performance enhancers - Google Patents

Separation of e nantiomers of cimaterol (-)-cimaterol and the use thereof as pharmaceutical composition or as performance enhancers

Info

Publication number
SG45439A1
SG45439A1 SG1996008586A SG1996008586A SG45439A1 SG 45439 A1 SG45439 A1 SG 45439A1 SG 1996008586 A SG1996008586 A SG 1996008586A SG 1996008586 A SG1996008586 A SG 1996008586A SG 45439 A1 SG45439 A1 SG 45439A1
Authority
SG
Singapore
Prior art keywords
cimaterol
nantiomers
separation
pharmaceutical composition
performance enhancers
Prior art date
Application number
SG1996008586A
Other languages
English (en)
Inventor
Wolfgang Resemann
Adolf Durr
Gunther Engelhardt
John Francis Quirke
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of SG45439A1 publication Critical patent/SG45439A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/111Aromatic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C07C255/59Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Animal Husbandry (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Fodder In General (AREA)
SG1996008586A 1990-05-04 1991-04-26 Separation of e nantiomers of cimaterol (-)-cimaterol and the use thereof as pharmaceutical composition or as performance enhancers SG45439A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4014252A DE4014252A1 (de) 1990-05-04 1990-05-04 Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Publications (1)

Publication Number Publication Date
SG45439A1 true SG45439A1 (en) 1998-01-16

Family

ID=6405664

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996008586A SG45439A1 (en) 1990-05-04 1991-04-26 Separation of e nantiomers of cimaterol (-)-cimaterol and the use thereof as pharmaceutical composition or as performance enhancers

Country Status (27)

Country Link
US (4) US5248695A (ja)
EP (2) EP0589488B1 (ja)
JP (1) JP2944777B2 (ja)
KR (1) KR0183024B1 (ja)
AR (1) AR247728A1 (ja)
AT (2) ATE124932T1 (ja)
AU (1) AU645313B2 (ja)
BG (1) BG60743B1 (ja)
CA (1) CA2041818C (ja)
CZ (1) CZ286389B6 (ja)
DE (3) DE4014252A1 (ja)
DK (2) DK0455155T3 (ja)
ES (2) ES2075255T3 (ja)
FI (1) FI109600B (ja)
GR (2) GR3017064T3 (ja)
HU (1) HU214335B (ja)
ID (1) ID966B (ja)
IE (2) IE69017B1 (ja)
IL (1) IL98030A (ja)
NO (1) NO174803B (ja)
NZ (1) NZ238032A (ja)
PT (1) PT97544B (ja)
RU (1) RU2002737C1 (ja)
SG (1) SG45439A1 (ja)
SK (1) SK279258B6 (ja)
TW (1) TW197415B (ja)
ZA (1) ZA913337B (ja)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer
GB2289842B (en) * 1991-04-05 1996-01-31 Sepracor Inc Improved use of ß2 bronchodilator drugs
GB9107196D0 (en) * 1991-04-05 1991-05-22 Sandoz Ag Improvements in or relating to organic compounds
EP0892639A4 (en) * 1996-01-29 1999-06-09 Savor Evelyn PROCESS FOR THE TREATMENT OF UNWANTED UTERINE CONTRACTIONS USING OPTICALLY PURE R OR RR ISOMERS OF AGONIST -g (b) -2 ADRENERGIC AGONISTS
JP2001527545A (ja) 1997-04-30 2001-12-25 ブリッジ ファーマ,インコーポレーテッド ユートマーを使用する組成物および方法
EP1787529A3 (en) * 1997-04-30 2009-11-18 Courage Corporation Pty Ltd. Composition and methods using an eutomer
ZA994264B (en) 1998-07-01 2000-01-25 Warner Lambert Co Stereoisomers with high affinity for adrenergic receptors.
US7232837B2 (en) 1999-06-29 2007-06-19 Mcneil-Ppc, Inc. Stereoisomers with high affinity for adrenergic receptors
EE200200602A (et) * 2000-04-27 2004-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pikatoimelised beetamimeetikumid, meetod nende valmistamiseks ja nende kasutamine ravimitena
US20030162459A1 (en) * 2002-02-27 2003-08-28 Osbon Robert Lindsay Method for producing a nonwoven fabric with enhanced characteristics
US20040235922A1 (en) * 2003-05-15 2004-11-25 Baile Clifton A. Compositions and methods for inducing adipose tissue cell death
EP1663197B1 (en) 2003-09-09 2007-12-05 Fumapharm AG The use of fumaric acid derivatives for treating cardiac insufficiency, and asthma
SG124283A1 (en) * 2004-03-24 2006-08-30 Trusted Hub Ltd Document signature method & system
DE602006015387D1 (de) 2005-04-13 2010-08-26 Astion Dev As Beta-2 Adrenoceptor Agonisten zur Behandlung von Bindegewebserkrankungen der Haut
US20090181369A1 (en) * 2005-05-27 2009-07-16 George Q Daley Methods for the Treatment of Disease
WO2006138243A2 (en) * 2005-06-13 2006-12-28 University Of Vermont And State Agricultural College Inhibition of creatine uptake to promote weight loss
MY176727A (en) 2012-12-03 2020-08-20 Pfizer Selective androgen receptor modulators

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL136601C (ja) * 1967-06-15
US4119710A (en) * 1972-12-18 1978-10-10 Boehringer Ingelheim Gmbh Bronchospasmolytic 1-(p-amino-phenyl)-2-amino-ethanols-(1) and salts
US4407819A (en) * 1980-08-25 1983-10-04 American Cyanamid Company Phenylethanolamine derivatives and acid addition salts thereof for the depression of fat deposition in warm blooded animals
US4814350A (en) * 1986-09-10 1989-03-21 American Cyanamid Company Method of treating diabetes with 5-[1-hydroxy-2-(isopropylamino)ethyl]anthranilonitrile
US4792546A (en) * 1986-12-05 1988-12-20 American Cyanamid Company Method for increasing weight gains and reducing deposition of fat in animals
DE4014252A1 (de) * 1990-05-04 1991-11-07 Boehringer Ingelheim Vetmed Enantiomerentrennung von cimaterol, (-)-cimaterol und dessen verwendung als arzneimittel oder als leistungsfoerderer

Also Published As

Publication number Publication date
IE911507A1 (en) 1991-11-06
EP0455155A1 (de) 1991-11-06
NO911746D0 (no) 1991-05-03
HU911502D0 (en) 1991-11-28
IE80651B1 (en) 1998-11-04
EP0455155B1 (de) 1995-07-12
CA2041818A1 (en) 1991-11-05
PT97544B (pt) 1998-08-31
NO174803B (no) 1994-04-05
JPH04225944A (ja) 1992-08-14
IL98030A0 (en) 1992-06-21
ES2075255T3 (es) 1995-10-01
US5395957A (en) 1995-03-07
AU645313B2 (en) 1994-01-13
NO911746L (no) 1991-11-05
CZ286389B6 (cs) 2000-03-15
IE69017B1 (en) 1996-07-24
CS129291A3 (en) 1991-11-12
DE4014252A1 (de) 1991-11-07
FI109600B (fi) 2002-09-13
ZA913337B (en) 1993-01-27
AU7611191A (en) 1991-11-07
DE59108853D1 (de) 1997-10-23
DE59105957D1 (de) 1995-08-17
AR247728A1 (es) 1995-03-31
GR3025547T3 (en) 1998-03-31
US5292753A (en) 1994-03-08
NO174803C (ja) 1994-07-13
BG60743B1 (bg) 1996-02-29
ES2109412T3 (es) 1998-01-16
TW197415B (ja) 1993-01-01
IL98030A (en) 1995-12-31
CA2041818C (en) 2003-02-11
FI912151A (fi) 1991-11-05
ATE158277T1 (de) 1997-10-15
EP0589488A1 (de) 1994-03-30
ID966B (id) 1996-09-30
JP2944777B2 (ja) 1999-09-06
SK279258B6 (sk) 1998-08-05
US5648386A (en) 1997-07-15
RU2002737C1 (ru) 1993-11-15
KR0183024B1 (ko) 1999-05-15
DK0455155T3 (da) 1995-11-13
HU214335B (hu) 1998-03-02
KR910019966A (ko) 1991-12-19
DK0589488T3 (da) 1998-05-04
EP0589488B1 (de) 1997-09-17
NZ238032A (en) 1996-02-27
ATE124932T1 (de) 1995-07-15
US5248695A (en) 1993-09-28
FI912151A0 (fi) 1991-05-03
HUT60999A (en) 1992-11-30
GR3017064T3 (en) 1995-11-30
PT97544A (pt) 1992-01-31
BG94342A (en) 1994-06-30

Similar Documents

Publication Publication Date Title
HU9602188D0 (en) Novel carbamate derivative and medicinal composition containing the same
AU5227890A (en) Composition and use
SG45439A1 (en) Separation of e nantiomers of cimaterol (-)-cimaterol and the use thereof as pharmaceutical composition or as performance enhancers
AP9200426A0 (en) Substance or composition and uses thereof
EP0435554A3 (en) Rubber compositions and preparation thereof
SG48141A1 (en) Composition of difluoromethane and tetrafluoroeth- ane
EP0304802A3 (en) Pharmaceutical composition and the use thereof
GB2289472B (en) CRT adhesive composition and CRT obtained by the use thereof
ZA929883B (en) Pharmaceutical composition and process for the preparation thereof
IL97122A0 (en) Aromatase-inhibiting androstendiones and pharmaceutical compositions containing them
AU1282395A (en) Novel benzamide derivative and medicinal composition containing the same
ZA924491B (en) Compositions and use thereof
AU631448B2 (en) Application aid and the use thereof
EP0438628A3 (en) Polymerisable mixture and its preparation
AU1106392A (en) Composition and use
ZA915677B (en) Solid pharmaceutical composition
EP0438629A3 (en) Polymerisable mixture and its preparation
SG47697A1 (en) N'-alkyl-spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
EP0483695A3 (en) Resin composition and use thereof
GB9016027D0 (en) Composition and use
ZA955128B (en) Novel amido-quinoxalinediones the preparation and use thereof
ZA911956B (en) 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances
EP0470669A3 (en) Preparation of fluorophenols, fluorohalophenols, n-acylfluoroanilines, and n-acylfluorohaloanilines
ZA922354B (en) Pharmaceutical composition and process for the preparation thereof
AU6797790A (en) Polycyclic nitrile compounds and pharmaceutical compositions thereof